DWT
GMAB icon

Dorsey & Whitney Trust’s Genmab GMAB Stock Holding History

Dorsey & Whitney Trust’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Buy
8,638
+552
+7% +$16.5K 0.01% 642
2025
Q4 		$249K Buy
8,086
+5
+0.1% +$156 0.01% 614
2025
Q3 		$248K Buy
+8,081
New +$197K 0.01% 595
2024
Q1 		– Sell
-6,576
Closed -$209K – 635
2023
Q4 		$209K Sell
6,576
-1,541
-19% -$48.4K 0.02% 568
2023
Q3 		$286K Buy
+8,117
New +$309K 0.02% 439

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dorsey & Whitney Trust's GMAB Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Genmab (GMAB) stake by 6.8% in Q1 2026, buying an estimated $16.5K and bringing the position to 8,638 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #642.

Dorsey & Whitney Trust first reported a position in GMAB in Q3 2023 and has held it in 5 quarters since. The position peaked at $286K in Q3 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Dorsey & Whitney Trust held 8,638 shares of Genmab worth $232K as of Q1 2026.
  • Dorsey & Whitney Trust bought 552 Genmab shares in Q1 2026, an estimated $16.5K.
  • Genmab made up 0.01% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #642 holding.
  • Dorsey & Whitney Trust first reported a position in Genmab in Q3 2023 and has held it in 5 quarters since.
  • Dorsey & Whitney Trust's Genmab position peaked at $286K in Q3 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.